General information
  • Disease category Mental and Behavioural diseases (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Lausanne
    (BASEC)
  • Contact Prof. Armando Marco marco.armando@chuv.ch (BASEC)
  • Data Source(s) BASEC: Import from 24.07.2025 ICTRP: N/A
  • Last update 24.07.2025 17:05
HumRes67104 | SNCTP000006502 | BASEC2024-02579

Treatment of Patients at High Risk of Psychosis Using Mentalization-Based Therapies. MBT-Psychosis.

  • Disease category Mental and Behavioural diseases (BASEC)
  • Recruitment status recruitment not started yet (BASEC/ICTRP)
  • Trial sites
    Lausanne
    (BASEC)
  • Contact Prof. Armando Marco marco.armando@chuv.ch (BASEC)
  • Data Source(s) BASEC: Import from 24.07.2025 ICTRP: N/A
  • Last update 24.07.2025 17:05

Summary description of the study

In this study, we would like to evaluate the effectiveness of Mentalization-Based Therapies (MBT) combined with needs-based clinical interventions (NBCI). NBCIs are the interventions that are always offered to all patients we follow who are experiencing potentially distressing or surprising experiences ('attenuated psychotic symptoms'). In this study, we want to see if Mentalization-Based Therapies coupled with NBCI provide more benefits for patients compared to patients who only receive basic clinical interventions (the NBCI).

(BASEC)

Intervention under investigation

Mentalization therapy consists of 24 sessions of individual psychotherapy supplemented by 6 sessions of 'family' therapy, aimed at improving the patient's ability to perceive, understand, and interpret their thoughts in the context of their relationships with others.

(BASEC)

Disease under investigation

Young patients aged 14 to 30 years at clinical high risk of psychosis

(BASEC)

Criteria for participation in trial
1- Patients aged between 14 and 30 years with a clinical high risk of developing psychosis. 2- Patients who have signed the study consent. (BASEC)

Exclusion criteria
1- Patients with an already established diagnosis of psychosis 2- Intellectual quotient; IQ < 70 3- Patients with psychotic symptoms under the influence of drugs or medications. 4- Patients who do not have sufficient proficiency in French 5- The parent/legal guardian does not give consent (minors only) 6 - Adult patients under guardianship (BASEC)

Trial sites

Lausanne

(BASEC)

not available

Sponsor

Centre Hospitalier Universitaire Vaudois (CHUV) Unité d'évaluation du risque psychotique à l'adolescence (ERA) Service de psychiatrie de l'enfant et de l'adolescent (SUPEA)

(BASEC)

Contact

Contact Person Switzerland

Prof. Armando Marco

+41 021 314 19 53

marco.armando@chuv.ch

CHUV

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee Vaud

(BASEC)

Date of authorisation

24.07.2025

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Mentalization Based Treatment (MBT) in help seeking youths with a Clinical High-Risk condition for Psychosis (CHR-P): a randomized controlled trial (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available